A groundbreaking new molecular mechanism has been discovered that could revolutionize the treatment of Parkinson's disease, the most common neurological disorder.
A groundbreaking new molecular mechanism has been discovered that could revolutionize the treatment of Parkinson's disease, the most common neurological disorder.
A recent study by the Department of Pharmacy published in Nature Communications discovered the correlation between this enzyme and alpha-sinuclein protein,...
Research by the Department of Pharmacy published in Nature Communications has discovered the correlation between this enzyme and alpha-sinuclein protein, whose abnormal accumulation in the brain is responsible for the development and progression of the disease.